BioInno Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $31.3M

  • Investors
  • 9

BioInno General Information

Description

Provider of CDMO process development and GMP production services. The company provides outsourcing services, specializing in developing cell therapy and gene therapy drugs for biotechnology and pharmaceutical companies.

Contact Information

Website
www.bioinnobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1107, Unit 3, Jinquan Times
  • Beiyuan Road, Chaoyang District
  • Beijing, 100101
  • China
+86 0512
Primary Industry
Biotechnology
Other Industries
BPO/Outsource Services
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 1107, Unit 3, Jinquan Times
  • Beiyuan Road, Chaoyang District
  • Beijing, 100101
  • China
+86 0512

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioInno Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 02-Dec-2021 $31.3M Completed Generating Revenue
2. Early Stage VC 23-Feb-2021 Completed Generating Revenue
1. Seed Round 01-Jul-2020 $1.41M $1.41M Completed Startup
To view BioInno’s complete valuation and funding history, request access »

BioInno Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
BridgeOne Capital China Venture Capital Minority
Ciit Asset Management Asset Manager Minority
Efung Capital Venture Capital Minority
Origins Capital Venture Capital Minority
Hangzhou Tigermed Consulting Company Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

BioInno FAQs

  • When was BioInno founded?

    BioInno was founded in 2019.

  • Where is BioInno headquartered?

    BioInno is headquartered in Beijing, China.

  • What industry is BioInno in?

    BioInno’s primary industry is Biotechnology.

  • Is BioInno a private or public company?

    BioInno is a Private company.

  • What is the current valuation of BioInno?

    The current valuation of BioInno is .

  • What is BioInno’s current revenue?

    The current revenue for BioInno is .

  • How much funding has BioInno raised over time?

    BioInno has raised $48.1M.

  • Who are BioInno’s investors?

    BridgeOne Capital China, Ciit Asset Management, Efung Capital, Origins Capital, and Hangzhou Tigermed Consulting Company are 5 of 9 investors who have invested in BioInno.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »